Hi mooers!
Chinese EV companies, $XPeng (XPEV.US)$ and $NIO Inc (NIO.US)$ are both scheduled to release their Q3 earnings this week, with XPEV's earnings on November 19 before bell and NIO's earnings on November 20 before bell.
The two companies are competitors at the Chinese Electric Vehicle market. In October, $NIO Inc (NIO.US)$ reported 20,976 vehicles delivery. $XPeng (XPEV.US)$ delivered 23,917 vehicles in October, setting a new record for i...

Industrial Production & Services
$PCHEM (5183.MY)$ Div: 2.31%
$PMETAL (8869.MY)$ Div: 1.43%
$SUNWAY (5211.MY)$ Div: 1.26%
$HAPSENG (3034.MY)$ Div: 6.23%
Health Care
$IHH (5225.MY)$ Div: 1.24%
$HARTA (5168.MY)$ Div: 0.00%
$KPJ (5878.MY)$ Div: 1.88%
$KOSSAN (7153.MY)$ Div: 1.19%
Transportation
$MISC (3816.MY)$ Div: 4.74%
$AIRPORT (5014.MY)$ Div: 1.03%
$WPRTS (5246.MY)$ Div: 4.03%
REITS
$KLCC (5235SS.MY)$ Div: 5.09%
$IGBREIT (5227.MY)$ Div: 4.80%
$SUNREIT (5176.MY)$ Div: 5.549%
Uti...

The outlook for future glove demand may exceed expectations, according to Kenanga Investment Bank. $TOPGLOV (7113.MY)$
The future performance is more optimistic, with a significant increase of 39% and 42% in net profit forecasts for the fiscal years 2025 and 2026 (ending at the end of August).
Following recent meetings with senior management of top glove, analysts at Kenanga Investment Bank are optimistic about the company's performance outlook.
"There are signs that top glove will experience a stronger demand rebound than expected after entering the 2025 fiscal year."
He added that top glove's sales continued to rise month by month in September this year, with the company also expecting customers' inventory replenishment activities to strengthen in the coming quarters.
"Currently, top glove's sales volume is increasing by 25% to 30% per month, aiming to improve overall capacity utilization to 65% to 70%. We originally predicted that the company's capacity utilization for the fiscal year 2025 would only be 55%."
In addition, the analyst pointed out that top glove's export volume to the USA continues to improve, now accounting for 28% to 30% of its global sales.
"Top glove believes this is due to stocking activities by US customers, coupled with more Chinese glove manufacturers being listed by the country's Food and Drug Administration (FDA) as a watchlist, while the capacity utilization of Chinese peers has also reached 90%, almost at full production capacity."
Analysts believe that top glove is optimistic about the price trend of average glove prices, predicting that the average price will gradually increase in the future, with a possible increase of 5% to 15%...